Marea Overview
- Year Founded
-
2022
- Status
-
Public
- Employees
-
41
Marea General Information
Description
Operator of a biotechnology company intended for the treatment of cardiometabolic diseases. The company specializes in the development of novel therapies for patients at risk for heart attacks, enabling patients to reduce remnant cholesterol and metabolic dysfunction and enhance the overall efficiency of the treatment process.
Contact Information
Website
www.mareatx.comCorporate Office
- 131 Oyster Point Boulevard Floor 4
- San Francisco, CA 94080
- United States
Corporate Office
- 131 Oyster Point Boulevard Floor 4
- San Francisco, CA 94080
- United States
Marea Timeline
Marea Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Marea Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Marea Comparisons
Industry
Financing
Details
Marea Competitors (79)
One of Marea’s 79 competitors is XyloCor Therapeutics, a Venture Capital-Backed company based in King of Prussia, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| XyloCor Therapeutics | Venture Capital-Backed | King of Prussia, PA | ||||
| Enterome | Venture Capital-Backed | Paris, France | ||||
| Verve Therapeutics | Formerly VC-backed | Boston, MA | ||||
| Cytokinetics | Formerly VC-backed | South San Francisco, CA | ||||
| Casma Therapeutics | Venture Capital-Backed | Cambridge, MA |
Marea Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Marea Patents
Marea Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025264615-A2 | Angiopoietin-like protein 4 antibody-based treatment | Pending | 17-Jun-2024 | ||
| WO-2025264615-A3 | Angiopoietin-like protein 4 antibody-based treatment | Pending | 17-Jun-2024 |
Marea Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Marea Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Marea FAQs
-
When was Marea founded?
Marea was founded in 2022.
-
Where is Marea headquartered?
Marea is headquartered in San Francisco, CA.
-
What is the size of Marea?
Marea has 41 total employees.
-
What industry is Marea in?
Marea’s primary industry is Biotechnology.
-
Is Marea a private or public company?
Marea is a Public company.
-
Who are Marea’s competitors?
XyloCor Therapeutics, Enterome, Verve Therapeutics, Cytokinetics, and Casma Therapeutics are some of the 79 competitors of Marea.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
